FAQs about Health » Mental Health » Substance Use Disorders » Alcohol Use Disorder
News about Health » Mental Health » Substance Use Disorders » Alcohol Use Disorder
Could weight loss drug benefit patients living with alcohol addiction, liver disease and obesity? - Loughborough University [Visit Site | Read More]
Once-weekly semaglutide versus placebo in patients with alcohol use disorder and comorbid obesity: a randomised, double-blind, placebo-controlled trial - The Lancet [Visit Site | Read More]
Semaglutide slimming jab study aims to help alcohol dependency - BBC [Visit Site | Read More]
GLP-1 plus therapy can reduce heavy drinking - National Institutes of Health (NIH) | (.gov) [Visit Site | Read More]
Neurobiological subtypes in alcohol use disorder and their phenotypic and clinical profiles | Molecular Psychiatry - Nature [Visit Site | Read More]
How to improve treatment for former Service personnel with both mental health and alcohol use disorders - Lancaster University [Visit Site | Read More]